Long-term Prognostic Significance of Pentraxin-3 in Patients with Non-ST Elevation Myocardial Infarction and Coronary Stenting

No abstract is available for this paper.

• Publication year

  2022

• Venue

  Namık Kemal tıp dergisi

• Publication date

  2022-06-22

• Fields of study

  Not labeled

• Identifiers
  DOI 10.4274/nkmj.galenos.2022.86548
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Increased Serum Pentraxin 3 Is Associated with Prediabetes and Type 2 Diabetes in Obese Patients with Nonalcoholic Fatty Liver Disease

  2021cited by this paper
• Long-term prognostic value of elevated pentraxin 3 in patients undergoing primary angioplasty for ST-elevation myocardial infarction

  2015cited by this paper
• Validation of a Novel Clinical Prediction Score for Severe Coronary Artery Diseases before Elective Coronary Angiography

  2014cited by this paper
• Angiographic score assessment improves cardiovascular risk prediction: the clinical value of SYNTAX and Gensini application

  2013cited by this paper
• Comparative diagnostic accuracy of serum levels of neutrophil activating peptide-2 and pentraxin-3 versus troponin-I in acute coronary syndrome.

  2011cited by this paper
• Inflammation in atherosclerosis: transition from theory to practice.

  2010cited by this paper
• Deficiency of the Long Pentraxin PTX3 Promotes Vascular Inflammation and Atherosclerosis

  2009cited by this paper
• Expression of pentraxin 3 (PTX3) in human atherosclerotic lesions

  2008cited by this paper
• Establishment of a High Sensitivity Plasma Assay for Human Pentraxin3 as a Marker for Unstable Angina Pectoris

  2007cited by this paper
• Pentraxins as a key component of innate immunity.

  2006cited by this paper
• Mortality rates in patients with ST-elevation vs. non-ST-elevation acute myocardial infarction: observations from an unselected cohort.

  2005cited by this paper
• C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease.

  2004cited by this paper
• Prognostic Significance of the Long Pentraxin PTX3 in Acute Myocardial Infarction

  2004cited by this paper
• The ENACT study: a pan-European survey of acute coronary syndromes. European Network for Acute Coronary Treatment.

  2000cited by this paper
• PTX3, A prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans.

  2000cited by this paper
• Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes.

  1996cited by this paper
• A more meaningful scoring system for determining the severity of coronary heart disease.

  1983cited by this paper

• No citing papers are available for this paper.